Tag Archives: biotechnology

Griffith Hack And Ambercite Map The Alzheimer’s Disease Patent Landscape

Posted on February 17, 2012 by Warren Woessner

Although I received this report: “Clearing The Fog; Patenting Trends For The Treatment Of Alzheimer’s Disease” both directly and from a number of colleagues, I won’t presume that it has been widely read, but it should be. (A copy of the … Continue reading →

Posted in Miscellaneous | Tagged alzheimer's disease, biotechnology, intellectual property, ip, patents, Warren Woessner | Leave a comment

AMP Petitions for Cert. and A Look Back

Posted on December 16, 2011 by Warren Woessner

The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged ACLU, AMP, Association of Molecular Pathology, biotechnology, biotechnology law, biotechnology news, BRCA DNA, Chakrabarty, diagnostic methods, Federal Circuit, Myriad, Myriad lawsuit, patent attorney, Patent Law, patents, SLW, Supreme Court, Warren Woessner | 1 Comment

Infringement by Unobvious Changes – A Look (Way) Back

Posted on October 16, 2011 by Warren Woessner

As a much younger attorney, I gave a presentation at the 1990 AIPLA Annual Meeting: “A Review of Recent Federal Circuit Decisions Relating to Infringement” (AIPLA Selected Legal Papers, 9, 3 (July 1991)), in which I wrestled with the question … Continue reading →